NOT GOOD—so it seems 🇬🇧 government researchers have discovered that the already more contagious #B117 has further acquired the other troublesome E484K mutation seen in 🇿🇦#B1351 & 🇧🇷#P1 variants—in 11 patients. E484k is blamed for partial vaccine-evasion.🧵
assets.publishing.service.gov.uk/government/upl…
2) Moreover, they believe the 11 samples of #b117 variant that acquired the new E484K acquired them independently of each other (not just one single origin). This suggests convergent evolution taking place—where it evolves to acquire E484K separately—which indicates it is key.
3) One expert thinks it’s because the E484K might enhance another mutation seen in #B117, thereby letting the virus “grip” the human ACE2 receptor (targeted entry portal into human cells) stronger in a more stable way.
4) Previously— the E484K mutation was shown in a recent study by @jbloom_lab
that E484 mutation (inside the #SARSCoV2’s spike’s critical receptor binding domain) seemed to somewhat escape neutralizing antibodies in 9 out of 11 people tested.
5) How much affect? the E484K shows a 10x reduction of neutralization (“neutralization” = stopping the virus)
by various antibodies compared to wildtype (common #SARSCoV2) in some patients —a rather bad thing. It means the virus with E484K is worrying for “immune escape”.
6) E484K mutation is also not a 1 time fluke. Scientists decided to see what mutations can help virus escape from patients w/ convalescent plasma immunity. So they soaked virus w/ CP over 12x times to speed evolution—80 days later—

*E484K arose*!
7) What does E484K mean for prior natural infection immunity and vaccines? Moderna has discovered its vaccine is less efficient for B1351 variant with E484K. But with discovery of E484K now acquired by some B117 variants—this is bad news. Hope it doesn’t become a super strain.
8) Moreover, in the latest E484K study by South Africa 🇿🇦 CDC @nicd_sa - not only 48% (of 44 formerly infected people tested) had “complete immune escape” to the SA variant #B1351 w/ E484K, but 90% of the people tested showed reduced immunity! That’s pretty large fraction.
9) This is why South African CDC has come out straightforward that the #B1351 variant with E484K mutation has serious potential for reinfection.
10) Similarly, the new Novavax vaccine had high efficacy for regular #COVID19 but much much lower in South Africa.
11) this was also recently seen in the single shot Johnson and Johnson vaccine — lower efficacy in South Africa.
12) Moderna, Pfizer/Biontech, Novavax, J&J have all expressed interest / already begun development of a booster shot #COVID19 vaccine dose for the new strain(s) with the E484K mutation.

current vaccine still DOES WORK, just not as efficiently as before for new variants w/ E484K.
13) Vaccines do still work. And even 50% for the few variants with the E484K is still good and better than 0% protection if you didn’t have any vaccine.

And the best news is that vaccines prevent severe #COVID19 and deaths the best!
14) Today, German chancellor Angela Merkel says that if vaccines do not work on variants of the virus, then "we start all over again” and has said coronavirus vaccines may be needed for "many years to come." She is a scientist herself.

amp.dw.com/en/angela-merk…
15) Pfizer and partner BioNTech are developing booster shots so that their COVID-19 vaccine Comirnaty can protect against new, highly contagious variants, Pfizer CEO Albert Bourla, Ph.D., said Tuesday, according to Bloomberg.

fiercepharma.com/pharma/first-m…
16) “Every time a new variant comes up we should be able to test whether or not [our vaccine] is effective. Once we discover something that it is not as effective, we will very, very quickly be able to produce a booster dose that will be a small variation to the current vaccine.”
17) Remember when I said the new E484K seems to have evolved separately in 2 different lineages of #B117 & somehow both converged to find E484K? So here is the genome lineage @nextstrain map—one recently evolved in Wales and one separately in England. Oy.
nextstrain.org/groups/neherla…
18) there is also the likelihood that #B117 will also yield more severe outcomes. 7 out of 10 studies suggests 30% increased mortality risk. See 🧵 for details.
19) This is why we need to avoid the new #B117 as much as possible. Switch to a premium mask for better inhalation filtration. It is CRITICAL folks. @AbraarKaran @RanuDhillon @sri_srikrishna all endorse.
20) a more contagious virus also means the threshold for reaching herd immunity is now becoming higher... lots of implications what this means and what we need to do...
21) We need to seriously start thinking about how to rapidly test and approve booster shots. I think they should be expedited now that we know the main #COVID19 is safe. Boosters are needed if these mutations keep arising.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Eric Feigl-Ding

Eric Feigl-Ding Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrEricDing

3 Feb
"None of us were able to predict" #COVID19 would mutate or variants would emerge, says Dido Harding, head of 🇬🇧 National Institute for Health Protection

➡️ Except every epidemiologist and immunologist expert!! 🤦🏻‍♂️ Image
3) Yes, and also every evolutionary biologist, virologist, geneticist, infectious disease physician, pathologist.... hell, I’ll even throw in X-men movie fans.
Read 6 tweets
3 Feb
OUTRIGHT FALSE—Gov Kristi Noem claims her “unique approach” helped South Dakota get through #COVID19 better than “virtually every other state”.

Data doesn’t lie—SD has had one of the highest cumulative incidence per capita and deaths per capita.
2) Here is high sky high S Dakota cumulative cases per capita is compared to other states. 12 out of every 100 people have been infected — that’s just the diagnosed count. Image
3) Here is the cumulative deaths per capita. 1 out of every 500 residents statewide in S Dakota has died of #COVID19 @KristiNoem. Let that sink in @govkristinoem. Image
Read 5 tweets
3 Feb
GOOD & BAD news for global COVAX vaccine allocations per nation. 336 mil doses to be distributed, but instead of 20%, countries can only expect to receive #COVID19 vaccine to cover on average **3.3%** of their population by Q2 2021. How many per country?🧵
gavi.org/sites/default/… Image
2) Most vaccines allocated will be the Oxford AstraZeneca vaccine - 240 mil. 96 mil will be the Pfizer / BioNTech vaccine. Here is the allocation for all countries alphabetically from A to Maldives... ImageImageImageImage
4) Here are the allocations for alphabetical countries Mali thru Z.

Keep in mind these are doses. And 2 doses needed for Oxford/AZ and Pfizer vaccines. Many countries getting tiny single % of what they need. This is a huge cut from 20%. ImageImageImage
Read 5 tweets
3 Feb
MUCH SHORTER EXPOSURE— #B117 is so infectious—very short exposure can lead to #COVID19. Many infected via just a few minutes inside a store. 🇨🇦 local health dept has shortened the exposure time to as little as ***1 second if not wearing face masks**. 🧵
theglobeandmail.com/canada/article… Image
2) spokeswoman for Ontario Health Minister Christine Elliott said on Sunday that the government has provided interim guidance to the province’s public-health units for screening and tracing contacts of cases associated with COVID-19 variants of concern.
3) “This guidance does include a lower threshold for classifying contacts as high risk of exposure and requiring quarantine,”
Read 12 tweets
3 Feb
BREAKING—Oxford-AstraZeneca not only protects people from serious illness and death but also substantially slows the transmission of #SARSCoV2, finding thr #COVID19 vaccine cuts transmission by nearly 2/3rds (pre print). It means it can slow the pandemic.🧵nytimes.com/2021/02/02/us/… Image
2) also, analyses reveal that a **single standard dose** efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month period for symptomatic #COVID19 Image
3) After the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used in the UK. (82.4% effective, with a 95% confidence interval of 62.7% - 91.7% at 12+ weeks) Image
Read 21 tweets
3 Feb
England 🏴󠁧󠁢󠁥󠁮󠁧󠁿 now has near total #B117 variant domination. It is now fully 97% of all #COVID19 cases in London. Total cases are down but B117 still up. Denmark 🇩🇰 also saw B117 fraction surge 70% increase per week after week even despite lockdown, total 🇩🇰 domination by end of Feb. Image
2) Denmark #B117. Total domination expected by Danish CDC by end of Feb.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!